Patient Leaflet Updated 28-Sep-2023 | axunio Pharma GmbH
Prucalopride 2 mg film-coated tablets
Prucalopride 2 mg film-coated tablets
Prucalopride succinate
Is this leaflet hard to see or read? Phone 0800 198 5000 for help.
1. What Prucalopride is and what it is used for
2. What you need to know before you take Prucalopride
3. How to take Prucalopride
4. Possible side effects
5. How to store Prucalopride
6. Contents of the pack and other information
Prucalopride contains the active substance prucalopride.
Prucalopride belongs to a group of gut motility enhancing medicines (gastrointestinal prokinetics). It acts on the muscle wall of the gut, helping to restore the normal functioning of the bowel.
Prucalopride is used for the treatment of chronic constipation in adults in whom laxatives do not work well enough.
Not for use in children and adolescents younger than 18 years.
Talk to your doctor before taking Prucalopride.
Take special care with Prucalopride and tell your doctor if you:
If you have very bad diarrhoea, the contraceptive pill may not work properly and the use of an extra method of contraception is recommended. See the instructions in the patient leaflet of the contraceptive pill you are taking.
Prucalopride film-coated tablets contain Isomalt (E 953):
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Tell your doctor if you are taking, or have recently taken, or might take any other medicines.
Prucalopride can be taken with or without food and drinks, at any time of the day.
Prucalopride is not recommended for use during pregnancy.
When breastfeeding, prucalopride can pass into breast milk. Breastfeeding is not recommended during treatment with Prucalopride. Talk to your doctor about this.
Ask your doctor for advice before taking any medicine.
Prucalopride is unlikely to affect your ability to drive or use machines. However, sometimes Prucalopride may cause dizziness and tiredness, especially on the first day of treatment, and this may have an effect on driving and use of machines.
Always take this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Take Prucalopride every day for as long as your doctor prescribes it.
The doctor may want to reassess your condition and the benefit of continued treatment after the first 4 weeks and thereafter at regular intervals.
The usual dose of Prucalopride for most patients is one 2 mg tablet once a day.
If you are older than 65 years or have severe liver disease, the starting dose is one 1 mg tablet once a day, which your doctor may increase to 2 mg once a day if needed.
Your doctor may also recommend a lower dose of one 1 mg tablet daily if you have severe kidney disease.
Taking a higher dose than recommended will not make the product work better.
Prucalopride is only for adults and should not be taken by children and adolescents up to 18 years.
It is important to keep to the dose as prescribed by your doctor. If you have taken more Prucalopride than you should, it is possible that you will get diarrhoea, headache and/or nausea. In case of diarrhoea, make sure that you drink enough water.
Do not take a double dose to make up for a forgotten tablet. Just take your next dose at the usual time.
If you stop taking Prucalopride your constipation symptoms may come back again.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects mostly occur at the start of treatment and usually disappear within a few days with continued treatment.
The following side effects have been reported:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
If pounding heart occurs, please tell your doctor.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is prucalopride.
One film-coated tablet of Prucalopride contains prucalopride succinate equivalent to 2 mg prucalopride.
The other ingredients are:
Tablet core
Microcrystalline cellulose (E 460 i); Isomalt (E 953); Sodium starch glycolate; Silica, colloidal anhydrous (E 551); Magnesium stearate (E 470 b)
Tablet coating
Hypromellose (E 464); Titanium dioxide (E 171); Macrogol; Talc (E 533 b)
Colourants
Iron oxide yellow (E 172)
Iron oxide red (E 172)
Indigo carmine aluminium lake (E 132)
Prucalopride 2 mg film-coated tablets are brown coloured, round, biconvex film-coated tablets debossed with ‘PRC’ on one side and ‘2’ on the other side. The average diameter of the tablets is 8.5 mm.
Prucalopride is available in packs of 7, 14, 28 or 84 film-coated tablets in aluminium/aluminium blister.
Prucalopride is available in packs of 7, 14, 28 or 84 film-coated tablets in clear- or opaque- PVC/PE/PVdC - aluminium blister.
Not all pack sizes may be marketed in your country.
Marketing authorisation holder
Manufacturer
This medicinal product is authorized in the Member States of the EEA and in the United Kingdom (Northern Ireland) under the following names:
Germany: Prucaloprid axunio 1 mg Filmtabletten
Prucaloprid axunio 2 mg Filmtabletten
Denmark: Prucalopride axunio 1 mg filmovertrukne tabletter
Prucalopride axunio 2 mg filmovertrukne tabletter
Schweden: Prucalopride axunio 1 mg filmdragerade tabletter
Prucalopride axunio 2 mg filmdragerade tabletter
United Kingdom: Prucalopride 1 mg film-coated tablets
Prucalopride 2 mg filmcoated tablets
This leaflet was last revised in November 2022.
V03
Van-der-Smissen-Strasse 1, Hamburg, 22767, Germany
+ 49 (0)40 - 38 02 32 09
https://axunio.eu/
+ 49 (0)40 - 38 02 32 14
+ 49 (0)40 - 38 02 32 14
+ 49 (0)40 - 38 02 32 14